MERCK & Co, Bristol-Myers Squibb and Ono Pharmaceutical Co have signed a US$625 million deal to resolve all global patent-infringement litigation related to cancer drug Keytruda.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jan 17